Overview

Methylene Blue in Sepsis: A Randomized Controlled Trial

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the addition of Methylene Blue to the standard treatment of septic shock will reduce vasopressor requirements
Phase:
N/A
Details
Lead Sponsor:
Queen's University
Collaborator:
The Physicians' Services Incorporated Foundation
Treatments:
Methylene Blue
Norepinephrine